Selected research
Industry Research
ChIP Sequencing Industry Research Report 2026
Market perspective
The global ChIP Sequencing market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the ChIP Sequencing market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the ChIP Sequencing market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the ChIP Sequencing market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of ChIP Sequencing include Illumina, BGI, Creative Biolabs, Thermo Fisher Scientific, Eurofins Genomics, Diagenode, Merck, Agilent and Zymo Research, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global ChIP Sequencing market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to ChIP Sequencing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
ChIP Sequencing Market by Company
Illumina
BGI
Creative Biolabs
Thermo Fisher Scientific
Eurofins Genomics
Diagenode
Merck
Agilent
Zymo Research
Chromatrap
Active Motif
ChIP Sequencing Segment by Type
Consumables and Reagents
Service
Other
ChIP Sequencing Segment by Application
Consumables and Reagents
Service
Other
ChIP Sequencing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global ChIP Sequencing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of ChIP Sequencing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of ChIP Sequencing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of ChIP Sequencing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Consumables and Reagents
- Service
- Other
Applications
- Consumables and Reagents
- Service
- Other
Companies covered
- Illumina
- BGI
- Creative Biolabs
- Thermo Fisher Scientific
- Eurofins Genomics
- Diagenode
- Merck
- Agilent
- Zymo Research
- Chromatrap
- Active Motif
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 ChIP Sequencing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Consumables and Reagents
- 2.2.3 Service
- 2.2.4 Other
- 2.3 ChIP Sequencing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Consumables and Reagents
- 2.3.3 Service
- 2.3.4 Other
- 2.4 Assumptions and Limitations
3 ChIP Sequencing Breakdown Data by Type
- 3.1 Global ChIP Sequencing Historic Market Size by Type (2021-2026)
- 3.2 Global ChIP Sequencing Forecasted Market Size by Type (2027-2032)
4 ChIP Sequencing Breakdown Data by Application
- 4.1 Global ChIP Sequencing Historic Market Size by Application (2021-2026)
- 4.2 Global ChIP Sequencing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global ChIP Sequencing Market Perspective (2021-2032)
- 5.2 Global ChIP Sequencing Growth Trends by Region
- 5.2.1 Global ChIP Sequencing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 ChIP Sequencing Historic Market Size by Region (2021-2026)
- 5.2.3 ChIP Sequencing Forecasted Market Size by Region (2027-2032)
- 5.3 ChIP Sequencing Market Dynamics
- 5.3.1 ChIP Sequencing Industry Trends
- 5.3.2 ChIP Sequencing Market Drivers
- 5.3.3 ChIP Sequencing Market Challenges
- 5.3.4 ChIP Sequencing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top ChIP Sequencing Players by Revenue
- 6.1.1 Global Top ChIP Sequencing Players by Revenue (2021-2026)
- 6.1.2 Global ChIP Sequencing Revenue Market Share by Players (2021-2026)
- 6.2 Global ChIP Sequencing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of ChIP Sequencing Head Office and Area Served
- 6.4 Global ChIP Sequencing Players, Product Type & Application
- 6.5 Global ChIP Sequencing Manufacturers Established Date
- 6.6 Global ChIP Sequencing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America ChIP Sequencing Market Size (2021-2032)
- 7.2 North America ChIP Sequencing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America ChIP Sequencing Market Size by Country (2021-2026)
- 7.4 North America ChIP Sequencing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe ChIP Sequencing Market Size (2021-2032)
- 8.2 Europe ChIP Sequencing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe ChIP Sequencing Market Size by Country (2021-2026)
- 8.4 Europe ChIP Sequencing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific ChIP Sequencing Market Size (2021-2032)
- 9.2 Asia-Pacific ChIP Sequencing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific ChIP Sequencing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific ChIP Sequencing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America ChIP Sequencing Market Size (2021-2032)
- 10.2 South America ChIP Sequencing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America ChIP Sequencing Market Size by Country (2021-2026)
- 10.4 South America ChIP Sequencing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa ChIP Sequencing Market Size (2021-2032)
- 11.2 Middle East & Africa ChIP Sequencing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa ChIP Sequencing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa ChIP Sequencing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Illumina
- 12.1.1 Illumina Company Information
- 12.1.2 Illumina Business Overview
- 12.1.3 Illumina Revenue in ChIP Sequencing Business (2021-2026)
- 12.1.4 Illumina ChIP Sequencing Product Portfolio
- 12.1.5 Illumina Recent Developments
- 12.2 BGI
- 12.2.1 BGI Company Information
- 12.2.2 BGI Business Overview
- 12.2.3 BGI Revenue in ChIP Sequencing Business (2021-2026)
- 12.2.4 BGI ChIP Sequencing Product Portfolio
- 12.2.5 BGI Recent Developments
- 12.3 Creative Biolabs
- 12.3.1 Creative Biolabs Company Information
- 12.3.2 Creative Biolabs Business Overview
- 12.3.3 Creative Biolabs Revenue in ChIP Sequencing Business (2021-2026)
- 12.3.4 Creative Biolabs ChIP Sequencing Product Portfolio
- 12.3.5 Creative Biolabs Recent Developments
- 12.4 Thermo Fisher Scientific
- 12.4.1 Thermo Fisher Scientific Company Information
- 12.4.2 Thermo Fisher Scientific Business Overview
- 12.4.3 Thermo Fisher Scientific Revenue in ChIP Sequencing Business (2021-2026)
- 12.4.4 Thermo Fisher Scientific ChIP Sequencing Product Portfolio
- 12.4.5 Thermo Fisher Scientific Recent Developments
- 12.5 Eurofins Genomics
- 12.5.1 Eurofins Genomics Company Information
- 12.5.2 Eurofins Genomics Business Overview
- 12.5.3 Eurofins Genomics Revenue in ChIP Sequencing Business (2021-2026)
- 12.5.4 Eurofins Genomics ChIP Sequencing Product Portfolio
- 12.5.5 Eurofins Genomics Recent Developments
- 12.6 Diagenode
- 12.6.1 Diagenode Company Information
- 12.6.2 Diagenode Business Overview
- 12.6.3 Diagenode Revenue in ChIP Sequencing Business (2021-2026)
- 12.6.4 Diagenode ChIP Sequencing Product Portfolio
- 12.6.5 Diagenode Recent Developments
- 12.7 Merck
- 12.7.1 Merck Company Information
- 12.7.2 Merck Business Overview
- 12.7.3 Merck Revenue in ChIP Sequencing Business (2021-2026)
- 12.7.4 Merck ChIP Sequencing Product Portfolio
- 12.7.5 Merck Recent Developments
- 12.8 Agilent
- 12.8.1 Agilent Company Information
- 12.8.2 Agilent Business Overview
- 12.8.3 Agilent Revenue in ChIP Sequencing Business (2021-2026)
- 12.8.4 Agilent ChIP Sequencing Product Portfolio
- 12.8.5 Agilent Recent Developments
- 12.9 Zymo Research
- 12.9.1 Zymo Research Company Information
- 12.9.2 Zymo Research Business Overview
- 12.9.3 Zymo Research Revenue in ChIP Sequencing Business (2021-2026)
- 12.9.4 Zymo Research ChIP Sequencing Product Portfolio
- 12.9.5 Zymo Research Recent Developments
- 12.10 Chromatrap
- 12.10.1 Chromatrap Company Information
- 12.10.2 Chromatrap Business Overview
- 12.10.3 Chromatrap Revenue in ChIP Sequencing Business (2021-2026)
- 12.10.4 Chromatrap ChIP Sequencing Product Portfolio
- 12.10.5 Chromatrap Recent Developments
- 12.11 Active Motif
- 12.11.1 Active Motif Company Information
- 12.11.2 Active Motif Business Overview
- 12.11.3 Active Motif Revenue in ChIP Sequencing Business (2021-2026)
- 12.11.4 Active Motif ChIP Sequencing Product Portfolio
- 12.11.5 Active Motif Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst